This is clinical study to test, for the first time in people, the safety (any good or bad effects), how long the drug can stay in the body and if it can control the disease of people diagnosed with advanced cancer that has not responded to treatment, has returned after it has been treated, or cannot be treated by surgery, drugs, or any other known treatments.

advanced basal cell carcinoma (BCC) (Cohort 2), Part A: advanced or unresectable solid tumors (STs) and relapsed and/or refractory (r/r) advanced non-Hodgkin's lymphomas (NHLs), Part B : r/r diffuse large B cell lymphoma (DLBCL) (Cohort 1), Part C: advanced or unresectable STs (Spain only), r/r DLBCL under an alternative dosing regimen (Cohort 3)

No related papers found yet.

None listed

Italy, Spain